Ghana targets first locally manufactured vaccine by 2027-NVI
Ghana is making progress towards manufacturing its first vaccine locally by 2027, with the first of three essential bulk substances required for production already in the country.
Ghana is on track to manufacture its first locally produced vaccine by 2027, according to the National Vaccine Institute (NVI). The first of three crucial bulk substances required for vaccine production has arrived in Ghana, according to NVI CEO Dr. Sodzi Sodzi-Tettey. The vaccine in question is a Tetanus-Diphtheria (Td) vaccine, which is an essential component of Ghana's efforts to increase its capacity for domestic vaccine production and decrease its reliance on imported supplies.
This milestone is part of Ghana's broader strategy to bolster its scientific research, healthcare, and biotechnology capabilities. President John Dramani Mahama recently commissioned two specialized laboratory facilities at the Noguchi Memorial Institute, which will bolster the country's scientific research and vaccine production capabilities.
The Tetanus-Diphtheria vaccine has been chosen as Ghana's inaugural locally manufactured vaccine, marking a significant step towards the country's goal of establishing a sustainable local vaccine manufacturing industry.
Written by urgent.news from MyJoyOnline Ghana's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Mahama commissions DNA testing and vaccine development laboratories at Noguchi Institute adomonline.com
- Mahama commissions DNA testing and vaccine development laboratories at Noguchi Institute myjoyonline.com
- Noguchi: Mahama commissions DNA, vaccine laboratories to boost Ghana’s health security starrfm.com.gh